Corixa/GSK Will Submit Bexxar-Zevalin Trial Protocol To FDA In January

Corixa and GlaxoSmithKline will conduct a head-to-head study of their non-Hodgkin's lymphoma treatment Bexxar and Idec's Zevalin, Corixa told FDA's Oncologic Drugs Advisory Committee Dec. 17